Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Enable Biosciences

Private
#Diagnostics#Autoimmune#Infectious Disease

Diagnostics company founded out of UC Berkeley and Stanford research, commercializing ultrasensitive antibody-detection tests for type 1 diabetes, HIV and Lyme disease.

Company Info

Sector:Diagnostics
Headquarters:South San Francisco, California, USA
Founded:2016
Website:www.enablebiosciences.com/

Clinical Development Pipeline

ADAP T1Define

Target: Ultrasensitive autoantibody detection
Type 1 diabetes autoantibody testing
Preclinical
Phase 1
Phase 2
Phase 3
Approved

ADAP HIV

Target: Ultrasensitive antibody detection
HIV antibody detection
Preclinical
Phase 1
Phase 2
Phase 3
Approved

ADAP Lyme

Target: Ultrasensitive antibody detection
Lyme disease serology
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

Careers & Job Openings

See all open roles

Careers
South San Francisco, California, USA
Apply Now →